Back
GT Biopharma, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20
GTBP
GT Biopharma, Inc.
Last Price:
$0.47
Seasonality Move:
-3.46%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and GTBP is experiencing slight buying pressure.
GT Biopharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.46 | Buy |
| 20-day SMA: | 0.49 | Sell |
| 50-day SMA: | 0.65 | Sell |
| 200-day SMA: | 1.29 | Sell |
| 8-day EMA: | 0.47 | Buy |
| 20-day EMA: | 0.51 | Sell |
| 50-day EMA: | 0.6 | Sell |
| 200-day EMA: | 1.2 | Sell |
GT Biopharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 40.98 | Sell |
| Chaikin Money Flow: | 329939 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.44 - 0.64) | Sell |
| Bollinger Bands (100): | (0.55 - 0.79) | Sell |
GT Biopharma, Inc. Technical Analysis
| Feb 13 | Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 13 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for GT Biopharma, Inc. Stock
Is GT Biopharma, Inc. Stock a Buy?
-
GT Biopharma, Inc. share price is 0.48 while GTBP 8-day simple moving average is 0.46, which is a Buy signal.
-
The stock price of GTBP is 0.48 while GT Biopharma, Inc. 20-day SMA is 0.49, which makes it a Sell.
-
GT Biopharma, Inc. 50-day simple moving average is 0.65 while GTBP share price is 0.48, making it a Sell technically.
-
GTBP stock price is 0.48 and GT Biopharma, Inc. 200-day simple moving average is 1.29, creating a Sell signal.
GTBP Technical Analysis vs Fundamental Analysis
Sell
20
GT Biopharma, Inc. (GTBP)
is a Sell
Is GT Biopharma, Inc. a Buy or a Sell?
-
GT Biopharma, Inc. stock is rated a SellThe current GT Biopharma, Inc. [GTBP] share price is $0.48. The Score for GTBP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
GT Biopharma, Inc. Stock Info
Market Cap:
12.7M
Price in USD:
0.48
Share Volume:
769.9K
GT Biopharma, Inc. 52-Week Range
52-Week High:
3.85
52-Week Low:
0.40
Sell
20
GT Biopharma, Inc. (GTBP)
is a Sell
GT Biopharma, Inc. Share Price Forecast
-
What is the GT Biopharma, Inc. stock price today?The GT Biopharma, Inc. stock price is 0.48 USD today.
-
Will GTBP stock go up or go down?GT Biopharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is GT Biopharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, GT Biopharma, Inc. is overvalued.
Is GT Biopharma, Inc. Stock a Buy?
-
GT Biopharma, Inc. share price is 0.48 while GTBP 8-day exponential moving average is 0.47, which is a Buy signal.
-
The stock price of GTBP is 0.48 while GT Biopharma, Inc. 20-day EMA is 0.51, which makes it a Sell.
-
GT Biopharma, Inc. 50-day exponential moving average is 0.60 while GTBP share price is 0.48, making it a Sell technically.
-
GTBP stock price is 0.48 and GT Biopharma, Inc. 200-day simple moving average is 1.20, creating a Sell signal.
Fundamental Analysis of GT Biopharma, Inc.
Is GT Biopharma, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.93 per share, and a decrease next year of $0.00 per share.
Technical Analysis of GT Biopharma, Inc.
Should I short GT Biopharma, Inc. stock?
-
GTBP Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting GT Biopharma, Inc. is a Sell
-
GT Biopharma, Inc. Relative Strength Index (RSI) is 40.98, which suggest GT Biopharma, Inc. is oversold
-
The Bollinger Bands (25) for GT Biopharma, Inc. is (0.44 - 0.64), which suggest GT Biopharma, Inc. is a Sell
-
The Bollinger Bands (100) for GT Biopharma, Inc. is (0.55 - 0.79), which suggest GT Biopharma, Inc. is a Sell
* GT Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.